| 000 | 01579 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513092448.0 | ||
| 264 | 0 | _c19960822 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1996.14.7.2054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, D H | |
| 245 | 0 | 0 |
_aPaclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJul 1996 |
||
| 300 |
_a2054-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aPaul, D M | |
| 700 | 1 | _aHande, K R | |
| 700 | 1 | _aShyr, Y | |
| 700 | 1 | _aBlanke, C | |
| 700 | 1 | _aMurphy, B | |
| 700 | 1 | _aLewis, M | |
| 700 | 1 | _aDe Vore, R F | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 14 _gno. 7 _gp. 2054-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1996.14.7.2054 _zAvailable from publisher's website |
| 999 |
_c8681064 _d8681064 |
||